|
US7411075B1
(en)
|
2000-11-16 |
2008-08-12 |
Teva Pharmaceutical Industries Ltd. |
Polymorphic form of atorvastatin calcium
|
|
IL156055A0
(en)
|
2000-11-30 |
2003-12-23 |
Teva Pharma |
Novel crystal forms of atorvastatin hemi calcium and processes for their preparation as well as novel processes for preparing other forms
|
|
US7501450B2
(en)
|
2000-11-30 |
2009-03-10 |
Teva Pharaceutical Industries Ltd. |
Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms
|
|
AP1571A
(en)
|
2001-06-29 |
2006-02-10 |
Warner Lambert Co |
Crystalline forms of 'R-(R* ,R*)!-2-(4- fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-'phenylamino)carbonyl!-1H-pyrrole-1-heptanoic acid calcium salt (2:1) (atorvastatin)
|
|
CZ296967B6
(cs)
*
|
2002-02-01 |
2006-08-16 |
Zentiva, A.S. |
Zpusob výroby amorfní formy hemivápenaté soli (3R,5R) 7-[3-fenyl-4-fenylkarbamoyl-2-(4-fluorfenyl)-5-isopropylpyrrol-1-yl]-3,5-dihydroxyheptanové kyseliny (atorvastatinu)
|
|
PL372241A1
(en)
|
2002-02-19 |
2005-07-11 |
Teva Pharmaceutical Industries Ltd. |
Processes for desolvating solvates of atorvastatin hemi-calcium and atorvastatin hemi-calcium essentially free of organic solvent
|
|
GB0218781D0
(en)
|
2002-08-13 |
2002-09-18 |
Astrazeneca Ab |
Chemical process
|
|
GB0312896D0
(en)
|
2003-06-05 |
2003-07-09 |
Astrazeneca Ab |
Chemical process
|
|
US7790197B2
(en)
|
2003-06-09 |
2010-09-07 |
Warner-Lambert Company Llc |
Pharmaceutical compositions of atorvastatin
|
|
US20050271717A1
(en)
|
2003-06-12 |
2005-12-08 |
Alfred Berchielli |
Pharmaceutical compositions of atorvastatin
|
|
US7655692B2
(en)
|
2003-06-12 |
2010-02-02 |
Pfizer Inc. |
Process for forming amorphous atorvastatin
|
|
AU2003247327A1
(en)
*
|
2003-07-15 |
2005-01-28 |
Eos Eczacibasi Ozgun Kimyasal Urunler Sanyi Ve Ticaret A.S. |
Process for the preparation of amortphous atorvastatin calcium without interconversion of any crystalline form
|
|
UY28501A1
(es)
|
2003-09-10 |
2005-04-29 |
Astrazeneca Uk Ltd |
Compuestos químicos
|
|
GB0324791D0
(en)
|
2003-10-24 |
2003-11-26 |
Astrazeneca Ab |
Chemical process
|
|
CZ298382B6
(cs)
*
|
2004-03-10 |
2007-09-12 |
Zentiva, A. S. |
Zpusob prípravy amorfní formy hemivápenaté soli atorvastatinu a její stabilizace
|
|
CA2560252C
(en)
*
|
2004-03-17 |
2009-08-04 |
Ranbaxy Laboratories Limited |
Process for the production of atorvastatin calcium in amorphous form
|
|
EP3581564A1
(en)
|
2004-05-05 |
2019-12-18 |
Pfizer Products Inc. |
Diethylamine salt forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid
|
|
JP2008506764A
(ja)
|
2004-07-20 |
2008-03-06 |
ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー |
[R−(R*,R*)]−2−(4−フルオロフェニル)−β、δ−ジヒドロキシ−5−(1−メチルエチル)−3−フェニル−4−[(フェニルアミノ)カルボニル]−1H−ピロール−1−ヘプタン酸カルシウム塩(2:1)の新規形態
|
|
WO2006021969A1
(en)
*
|
2004-08-27 |
2006-03-02 |
Biocon Limited |
Process for atorvastatin calcium amorphous
|
|
KR20070106680A
(ko)
*
|
2004-09-30 |
2007-11-05 |
닥터 레디스 레보러터리즈 리미티드 |
비정질 아토르바스타틴 칼슘
|
|
KR20070067175A
(ko)
*
|
2004-10-28 |
2007-06-27 |
워너-램버트 캄파니 엘엘씨 |
무정형 아토르바스타틴 형성 방법
|
|
WO2006048888A1
(en)
*
|
2004-11-01 |
2006-05-11 |
Jubilant Organosys Limited |
Novel process for the preparation of amorphous atorvastatin calcium salt
|
|
ES2263370B1
(es)
*
|
2005-02-16 |
2007-12-01 |
Ercros Industrial, S.A. |
Atorvastatina calcica amorfa estabilizada y procedimiento para su obtencion.
|
|
WO2007052296A2
(en)
*
|
2005-08-23 |
2007-05-10 |
Kopran Research Laboratories Ltd |
A process of preparing amorphous atorvastatin calcium
|
|
ES2270722B1
(es)
*
|
2005-09-15 |
2008-03-01 |
Ercros Industrial, S.A. |
Procedimiento para la obtencion de atorvastatina calcica amorfa.
|
|
CA2547216A1
(en)
|
2005-09-21 |
2007-03-21 |
Renuka D. Reddy |
Process for annealing amorphous atorvastatin
|
|
US8084488B2
(en)
|
2005-11-21 |
2011-12-27 |
Pfizer Inc. |
Forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid magnesium
|
|
US20090111997A1
(en)
*
|
2005-11-23 |
2009-04-30 |
Aaron Cote |
Method of Generating Amorphous Solid for Water-Insoluble Pharmaceuticals
|
|
EP2185527A2
(en)
*
|
2007-07-11 |
2010-05-19 |
Actavis Group PTC EHF |
Novel polymorph of atorvastatin calcium and use thereof for the preparation of amorphous atorvastatin calcium
|
|
WO2009082362A1
(en)
*
|
2007-11-05 |
2009-07-02 |
Ulkar Kimya San. Ve Tic. A.S. |
A method for producing statins in pure form
|
|
EP2075246A1
(en)
|
2007-12-27 |
2009-07-01 |
M. J. Institute of Research |
A process for preparation of amorphous form of atorvastatin hemi-calcium salt
|
|
WO2009090544A2
(en)
*
|
2008-01-16 |
2009-07-23 |
Matrix Laboratories Limited |
Process for producing amorphous atorvastatin calcium
|
|
WO2009139730A1
(en)
*
|
2008-05-13 |
2009-11-19 |
Ulkar Kimya San. Ve Tic. A.S. |
Preparation of novel non-crystalline forms of atorvastatin calcium
|
|
CN113321607A
(zh)
*
|
2020-02-28 |
2021-08-31 |
北京福元医药股份有限公司沧州分公司 |
一种阿托伐他汀钙中间体的纯化方法
|
|
CN114213270B
(zh)
*
|
2021-12-17 |
2024-05-28 |
江苏阿尔法药业股份有限公司 |
一种利用连续流微通道反应器合成阿托伐他汀钙中间体的方法
|